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Abstract

Research is the necessary foundation for health care advancement and understanding.
Significant challenges exist, however, with recruiting and engaging underrepresented
populations in clinical research. The purpose of the scholarly project was to determine how
stakeholder race, trust, and level of education influence participation barriers in clinical research.
The project utilized secondary, cross sectional survey data that were collected between 2014 and
2016 through the former Mid-South Clinical Data Research Network (CDRN), currently known
as the STAR-CRN. Descriptive statistics and spearman rank correlations were performed
between level of education, level of trust, and each attitude statement for each racial category. A
total of 2,149 survey responses were used in the data analysis. The mean age of respondents was
52 years old (SD=15.65) with majority being female (69.0%, n=1496), white (77.7%, n=1701),
insured (76%, n=1610), and working full time (50.4%, n=1078). Overall, the respondents had
favorable attitudes towards research participation. Trust was associated with agreement in each
attitude statement from both white and AA respondents (p<.001), while correlations with
education level was more variable depending on racial grouping. Trust level was negatively
associated with agreement towards the statement “Researchers don’t care about me” in White
(CC=-.492; p=.000), AA (CC=-.188; p=.000), Asian (CC=-.429; p=.041), and Middle Eastern
(CC=-.864; p=.003) respondents. The results support the importance of trust within the patient
and provider relationship. Generally, education level is not a largely predictive variable in its
influence of research participation, although it shows stronger evidence of influence depending
on race and attitude statement.
Keywords: trust, race, education, participation, clinical research, underrepresented, adults
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Predictors of barriers to participation in clinical research
in adults living in the Southeastern United States
Introduction and Background
At the turn of the 21st century, the Institute of Medicine (IOM) released the article,
Crossing the Quality Chasm, which emphasized the need for an effective, equitable, and patientcentered health care delivery system (Agency for Healthcare Research and Quality [AHRQ],
2018). Effective health care refers to providing appropriate medical services based on scientific
knowledge to those who could benefit, while refraining from services that are likely
nonbeneficial (AHRQ, 2018). Equitable health care does not vary in quality based on patientspecific characteristics like race, socio-economic status, or geographic location (AHRQ, 2018).
Patient-centered care (PCC) views a patient holistically and is grounded in the idea of mutuality
between the patient and medical provider. The goal is to ultimately attain the best health
outcomes for the patient (Beattie, Shepherd, Howieson, 2012). In order to provide effective and
equitable care to all individuals, health care research in the domain of patient centeredness is
necessary (Beattie et al., 2012).
Health care research is a general term that includes a variety of research methodologies
that ultimately develop or provide knowledge regarding disease, risk factors, outcomes of
treatment, public health interventions, functional abilities, patterns of care, and health care usage
(Beattie et al., 2012). For example, a medical provider may decide to treat a young African
American woman with hypertension differently compared to an older Caucasian woman based
on what research shows to be most effective. It is through research that the goal of equitable,
effective, and patient centered health care can be attained.
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Although research is the necessary foundation for health care advancement and
understanding, significant challenges exist with recruiting and engaging underrepresented
populations into health care research. The National Institutes of Health (NIH) recognize African
Americans (AA), American Indians (AI), Alaskan Natives (AN), Hispanics, Native Hawaiians
(NH), and other Pacific Islanders (PI) as underrepresented populations in research studies
(National Institutes of Health [NIH], 2018). Although increasing minority participation in
clinical trials has been a priority in the country since the NIH Revitalization Act of 1993,
participation rates in minority populations remain low compared to the percentage of minorities
in the entire United States’ (US) population (Reifenstein & Asare, 2018).
In 2017, the FDA reported 81% of clinical trial participants as Caucasian, 14% AA, 2.7%
Asian, and the remaining 2.3% were Hispanic, PI, AI, AN, and NH populations (Food and Drug
Administration [FDA], 2017). The participants were not representative of the entire US
population in that 61% were Caucasian, 18% were Hispanic or Latino and 15% were African
American, 5% were Asian, and 2% were AI or PI (United States Census Bureau, 2017).
Although minority populations are underrepresented in clinical research, they face the greatest
health disparities (AHRQ, 2015).
The 2015 National Healthcare Quality and Disparities Report documents that minority
populations receive poorer quality of care and face greater barriers in accessing care compared to
white populations (AHRQ, 2015). In addition, AA, AI, and Hispanics have greater rates of
preventable hospitalizations and higher mortality rates compared to white populations (AHRQ,
2015). Incidence of specific diseases, cancers, and reactions to medications and treatments differ
between races and ethnicities. For example, AA men have a greater incidence of prostate cancer
compared to Caucasian men. AA women have the same incidence of breast cancer as Caucasian
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women, however, have higher mortality rates (Ahaghotu, Tyler, & Sartor, 2015; Reifenstein &
Asare, 2018). In addition, Hispanics and AAs have the greatest prevalence of diabetes and
adolescent obesity compared to Caucasians (CDC, 2015). Similarly, almost half of all AA adults
have some form of cardiovascular disease compared to about one third of Caucasian adults
(Reifenstein & Asare, 2018). In addition to health disparities, the effectiveness of treatment
modalities differs between races. Clopidogrel, an antiplatelet drug is highly effective for
Caucasians but has no greater affect than a placebo in 75% of Pacific Islanders (Wu, White, Oh
& Buchard, 2015). Due to the disparities present, it is necessary to recruit and engage diverse
populations in order to create equitable health systems. However, engaging and recruiting
participants to accurately represent the diversity of the population is challenging process
(Cunningham-Erves et al., 2017).
Problem Statement
Research participants, also referred to as stakeholders in patient centered research studies,
are needed from diverse populations (i.e. racial ethnic minorities, sexual gender minorities,
variation in geographic locations and differing abilities) in order to identify relationships
between numerous socio-cultural and biologic variables, ensure reliable data, and to ultimately
determine equitable, effective, and patient-centered health outcomes and solutions for all patients
(Centers for Disease Control [CDC], 2013; Cunningham-Erves et al., 2017; FDA, 2018; Lin &
Kelsey, 2000). Although there is a great need in engaging diverse samples of participants for
research as mentioned previously, recruiting and engaging participants remains a challenge.
In 2014, the National Patient-Centered Clinical Research Network was established by the
Patient-Centered Outcomes Research Institute (PCORI) with the goal of transforming the culture
of clinical research through patient-centered engagement and recruitment (Unertl et al., 2018).
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Utilizing the multiple healthcare facilities and millions of patients in the network, the STARCRN (Stakeholders, Technology, and Research CRN, n.d.), formally known as the Mid-South
Clinical Data Research Network (CDRN), a sub-unit of the National Patient-Centered Clinical
Research Network, aims to increase the number of research participants through their diverse
patient network. In order to effectively engage patients in the diverse STAR-CRN network, it is
necessary to identify the barriers that these specific patients encounter at any point in the
research process.
Purpose and Hypothesis
The purpose of the scholarly project was to determine how stakeholder race, trust, and level
of education influence participation barriers in clinical research. Improved understanding of
predictors will offer insight on how to effectively engage and educate patients living in the
southeastern United States who receive healthcare services through facilities associated with the
STAR-CRN. Based on the reviewed evidence, the researchers hypothesize that race, trust level,
and level of education are predictors of barriers to participation in clinical research.
Review of Evidence
Extensive literature exists regarding participation barriers in research and variables that
can influence a stakeholder’s willingness to participate. Barriers identified include the
participant’s level of trust, access to research information, fear of the unknown or adverse
effects, inconvenience, and reputation of researchers and research institutions (George, Duran, &
Norris, 2014; Williams et al., 2010).
Trust
The concept of trust is discussed and examined in health care literature specifically due to
relationship dynamics between healthcare professionals and patients (Dibben, Morris, & Lean,
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2000; Hall et al., 2001; Hupcey, Penrod, Morse, & Mitcham, 2001; Goudge & Gilson, 2005).
Trust is defined as the degree to which the patient relies, depends, and is confident in the
provider (Armstrong, Ravenell, McMurphy, & Putt, 2007). Trust is present in situations of risk,
uncertainty, or unequal status where there is a level of dependence on another individual
(Kerasidou, 2017; Thielmann & Hilbig, 2015) creating a relationship of vulnerability (Hall et al.,
2001). In the case of a patient and medical researcher, an asymmetrical relationship exists
between the researcher’s authority and patient role.
Many variables identified throughout literature act as barriers and facilitators to
participant trust in clinical research (George, Duran, & Norris, 2014). Barriers to trust include
inadequate information regarding research studies, unethical behavior by the research team, and
safety concerns (Ceballos et al., 2014; Cortes et al., 2017; Cunningham-Erves et al., 2016;
George et al., 2014; Owens et al., 2013; Scharff et al., 2010; Williams et al., 2010). Many
individuals believe that collected samples like blood, urine, saliva, or stool are unethically
disposed of or used after the research study without permission (Ceballos et al., 2014; Kraft et
al., 2018). In addition, study participants expressed fear of taking medications that would cause
adverse effects (Cortes et al., 2017), receiving unnecessary surgery (Cortes et al., 2017),
experiencing unintended consequences of the study (George et al., 2014), having personal
information be used against the participant (Cortes et al., 2017; Scharff et al., 2010) and being
treated like “guinea pigs” or “lab rats” (Cunningham-Erves et al., 2016, Durant et al., 2011,
George et al., 2014; Owens et al., 2013; Scharff et al., 2010; Williams et al., 2010).
Facilitators to participant trust in clinical research include the patient’s relationship with
the research team (Burkett & Morris, 2014; Byrne et al., 2014; Cortes et al., 2017; George et al.,
2014; Getrich et al., 2013; Gupta et al., 2014; Kraft et al., 2018; Owens et al., 2013; Paquette &
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Derrington, 2018; Scharff et al., 2010; Williams et al., 2010), a thorough and educational
research consent process (Cortes et al., 2017; George et al., 2014; Kraft et al., 2018, Owens et al.,
2013), and extensive research study oversight (Kraft et al., 2018; Paquette & Derrington, 2018).
Individuals are more likely to participate in a study if they feel well informed about the study and
know they have the right to withdraw at any point (Cortes et al., 2017; George et al., 2014).
Study participants report greater feelings of trust and willingness to participate in research
knowing that researchers are being held accountable by leadership teams (Kraft et al., 2018;
Paquette & Derrington, 2018). In addition, participants voiced wanting to know about the
research funding and how the data library was being managed (Kraft et al; 2018; Williams et al.,
2010). Participants’ understanding of the research team behind the study facilitated greater trust
by the participant (Kraft et al., 2018; Paquette & Derrington, 2018; Williams et al., 2010).
Race and ethnicity
Race and ethnicity are variables that not only influence patient participation in research
but also influence trust. Due to historic and recent events of segregation, racism, and unequal
civil rights, African Americans report less willingness to participate in research compared to
Caucasians (Dunlop, Leroy, Logue, Glanz & Dunlop, 2011; Durant et al., 2011; George et al.,
2014; Kraft et al, 2018; Ma et al., 2012; Owens et al., 2013; Scharff et al., 2010; Westergaard et
al., 2013; Williams et al., 2010). A variety of studies reference the Tuskegee Syphilis Study that
was conducted from the 1930s to the 1970s that left the African American community fearful
and distrusting in the process of research (Alsan & Wanamaker, 2018; Durant et al., 2011;
George et al., 2014; Ma et al., 2012; Owens et al., 2013; Scharff et al., 2010; Williams et al.,
2010). The study permitted hundreds of adult AA men with syphilis to go untreated despite the
availability of effective treatment, Penicillin (Alsan & Wanamaker, 2018). In addition, the
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treatment of Henrietta Lacks and her family in the 1950s continues to alter the perspectives of
AAs towards healthcare institutions and American society (Kraft et al., 2018). Henrietta Lacks
was an AA woman whose cells, collected from a cervical cancer biopsy, were later developed
into the HeLa cell line. HeLa cells were commercialized and highly profitable in the healthcare
world, however, the Lacks family did not gain any profit from her biospecimen (Lee et al.,
2019).
Hispanic individuals also face specific cultural and racial variables that influence
participation in clinical research (Ceballos et al., 2014; Kraft et al., 2018; Ulrich et al., 2013;
Westergaard et al., 2013). Some study participants expressed their willingness to participate in
research but have limited understanding of the healthcare system due to immigration to the
United States later in their lives (Ceballos et al., 2014; Kraft et al., 2018; Ulrich et al., 2013). In
addition, individuals expressed fear of racial discrimination (Ceballos et al., 2014; Ulrich et al.,
2013; Westergaard et al., 2013) and misunderstanding due to language barriers (Ceballos et al.,
2014; Westergaard et al., 2013).
Education
An individual’s education level is discussed within research literature in the context of
research participation. Education level affects an individual’s literacy and understanding (Asare,
Flannery & Kamen, 2017), therefore theoretically affecting what a participant knows and
understands about research. In one study measuring recruitment and participation in clinical
research (n=5,154), individuals with increased levels of education, particularly college graduates,
were more likely to participate (Baquet, Commiskey, Mullins & Mishra, 2006). The results were
consistent with a different study where 97% of participants were college educated and reported
favorable views of research and willingness to participate in clinical trials (Brewer et al., 2014).
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In a study measuring African Americans’ willingness to participate in research before and after a
pre-consent education session (n=192), individuals with a high school level of education or less
were significantly more likely to participate in a clinical trial after receiving pre-consent
education (Dunlop et al., 2011). Although past literature explores the relationship between
education level and an individual’s participation in research, convincing evidence of the
relationship between an individual’s education level and perspectives on research participation is
lacking.
Location
Race, trust, and education are variables in this scholarly project because they are seen
throughout literature as predictors to patient participation. Although barriers to research
participation have been studied previously, further research is justified because there is
geographic variation in research participation barriers throughout the United States (Armstrong
et al., 2007). Individuals living in urban areas report greater distrust compared to those in rural
areas, yet rural participants report lack of interest in participating in clinical trials compared to
urban areas (Friedman, Bergeron, Foster, Tanner & Kim, 2013). In another study, participants
living in rural Maryland were less likely to participate in research compared to participants living
in urban Maryland (Baquet et al., 2006). Due to geographic variation, collecting data from
patients who receive care from medical providers that belong in a specific healthcare network,
specifically those affiliated with the STAR-CRN, can be beneficial for developing accurate
implementation methods to engage that same population for research.
Theoretical Model
The Social Cognitive Theory (SCT) by Albert Bandura (1971) provided the theoretical
framework for the scholarly project. The Social Learning Theory was initially developed in the
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1960s while Bandura was studying the learned behaviors of children. The theory was later
updated into the Social Cognitive Theory in 1986 (LaMorte, 2019). The theory explains how
individuals learn and maintain behaviors in the social context in which they live. The theory
includes the construct of reciprocal determinism which considers the continual interaction
between cognitive, environmental, and behavioral factors to ultimately determine human
behavior (Ozylimaz, Erdogan, & Karaeminogullari, 2018). Cognitive factors, also called
personal factors, include an individual’s knowledge, expectations, and attitudes. Environmental
factors include societal and cultural norms, community access and resources, and the influence
of others. Behavioral factors include skills, practice, and an individual’s self-efficacy.
The triadic reciprocal relationship between cognitive factors, the environment, and human
behavior explains the theorized relationship between variables in the scholarly project. Refer to
Figure 1 for a model of the SCT in relation to the variables being examined. The independent
variables of the scholarly project included the individual’s level of trust towards clinical
research, race, and level of education. Each independent variable was classified as a personal
factor within the theory. Barriers to participating in research were the dependent variables of the
scholarly project. One can assume if no barriers to participating exist, an individual would
therefore participate in research. Participation in clinical research was classified as the behavior
in the theoretical model. Environmental factors include the physical, social and cultural context
in which an individual lives.
Although the scholarly project did not directly include environmental factors as study
variables, literature consistently displays that environmental factors are closely tied to race and
trust level. Current and historic racism and societal segregation create neighborhoods and cities
with unequal opportunities and resources. When comparing communities with similar poverty
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rates, neighborhoods that are predominantly African American or Hispanic have fewer grocery
stores, parks, and gyms than predominately white neighborhoods (Brooks, 2014; Firebaugh &
Acciai, 2016). In addition, African American men report greater perception of racial
discrimination in health care compared to white men (Assari et al., 2017). As stated previously in
the review of literature, past studies reveal that level of trust and willingness to participate in
research varies geographically. Therefore, environmental factors, although not a variable that is
being measured directly within the scholarly project, are directly tied to the variables of interest
and require inclusion within the theoretical framework.
In the context of the scholarly project, the researcher can theoretically predict behavior, as
in, participation in clinical research, with consideration of the various factors that influence that
human behavior. An individual who does not understand research or has little trust in medical
research may be less likely to engage in research. Comparatively, an individual with greater
amounts of trust towards medical research and a higher level of education may be more likely to
participate in research.
Project Design
The scholarly project utilized secondary, cross sectional survey data that were collected
between 2014 and 2016 through the former Mid-South Clinical Data Research Network
(CDRN), currently known as the STAR-CRN. The surveys were handed out throughout clinics
within the former Mid-South CDRN after receiving approval from the Vanderbilt University
Institutional Review Board (IRB). To utilize the de-identified data for the scholarly project, the
Belmont University IRB approved the project as exempt in April 2019.
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Clinical Setting
The former Mid-South CDRN conducted research across numerous healthcare delivery
sites throughout the Southeastern US. The major medical sites associated with the former MidSouth CDRN included Vanderbilt University Medical Center, Meharry Medical College, the
Vanderbilt Healthcare Affiliated Network, Greenway Health, and the Carolinas Collaborative.
Although the former Mid-South CDRN, now known as the STAR-CRN, is expansive
throughout the southeast, the survey was specifically distributed to patients visiting a Vanderbilt
University or Meharry/Metro General hospital or clinic. Practice settings of the former MidSouth CDRN included, Vanderbilt University Medical Center, Vanderbilt University Children’s
Hospital, Vanderbilt University Stallworth Rehabilitation Hospital, Vanderbilt University
Psychiatric Hospital, Meharry/Metro General Hospital, and Matthew Walker Community Health
Center.
Project Population
The research participants were adults (18 years old and older) living in the Southeastern
United States who received care at least one time from a provider at one of the aforementioned
clinical sites. There were no further inclusion or exclusion criteria.
Data Collection Instruments
Between 2014 and 2016, approximately 5,000 patients in the CDRN were surveyed to
identify barriers that impede patient involvement in research. Two parallel surveys were
administered using a random process (Cunningham-Erves, Villalta-Gil, Wallston, Boyer, &
Wilkins, 2019). The surveys differed by tools that measured the concept of trust. One survey
included the tool, Hall-Trust in Medical Research (Hall et al., 2006) while the other included
Mainous-Trust in Medical Research (Mainous, Smith, Geesey, & Tilley, 2006). The Scholarly
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Project only utilized data collected from the survey containing the tool, Trust in Medical
Research (items 67-78) by Hall et al. (2006). All surveys were administered using REDCap
(Harris et al., 2019). Refer to appendix A for a copy of the survey.
Race, ethnicity, and level of education were collected in the demographic portion of the
survey (items one through 24). The tool Trust in Medical Research (items 67 to 78) by Hall et al.
(2006) was used to measure the respondent’s level of trust in medical research. The trust tool
was developed initially through a pilot study with a 25-item questionnaire. It was then simplified
by following an item-reduction procedure to develop the current 12-item tool (Hall et al., 2006).
The Cronbach alpha coefficient was 0.87 and the response pattern was normally distributed (Hall
et al., 2006).
Questions to assess barriers to participation in medical research (items 54 to 66) were
taken from a previous study by Mouton, Harris, Rovi, Solorzano, & Johnson (1995) using a fivepoint Likert scale for each statement ranging from strongly agree to strongly disagree. The
specific questions were created from a literature review of barriers to participation in research. A
panel of four experts reviewed the 12- question instrument for clarity, content validity, and
cultural sensitivity. The content validity and cultural sensitivity both scored as 1.0 (MillonUnderwood, Sanders, & Davis, 1993).
Data Collection Process
Participants were recruited in person at the aforementioned clinics. Prior to receiving a
survey, participants were informed of the purpose, time commitment, risks and benefits, and
compensation. Compensation included a $25.00 gift card with the completion of the survey.
The results of the survey were stored in a secure dataset through the Meharry Vanderbilt
Alliance (MVA). In order for the project leader to access the secondary data, the Belmont
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University IRB approval was obtained in April 2019. Next, a data-usage agreement through
MVA was signed by the project leader. The project leader obtained the dataset in August 2019.
Statistical Analysis
The dataset was organized and cleaned in Microsoft Excel. Initially, the dataset included
4,700 respondents from two different surveys. The researcher removed the respondents from the
dataset that did not obtain the survey that was used for the scholarly project. A total of 2,149
respondents remained after deletion. The percentage of missing data was calculated for each
survey measure. Each measure had less than 5% missing data. A response mean for each
measure was calculated to fill in missing data.
IBM SPSS Statistics, version 26 was used for the statistical analysis. Descriptive statistics
were performed on the variables of level of education, trust level, race, and each attitude
statement in the barriers to participation scale. Next, a spearman rank correlation was performed
between level of education, level of trust, and each attitude statement for each racial category.
Results
A total of 2,149 survey responses were used in the data analysis. Sociodemographic
characteristics of survey respondents are shown in Table 1. The mean age of respondents was 52
years old (SD=15.65) with majority being female (69.0%, n=1496), white (77.7%, n=1701),
insured (76%, n=1610), and working full time (50.4%, n=1078). The mean trust score was 39.85
(SD=6.7). Trust scores by racial grouping are shown in Table 2. Middle Easterners reported the
least amount of trust (M=36.11, SD=5.8) compared to other groups. The majority of respondents
had at least two years of college education (85.3%, n=1836). Education levels are separated by
racial groupings in Table 3. Very few respondents in each racial grouping had less than an 8th
grade education.
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Overall, the respondents had favorable attitudes towards research participation.
Percentage of respondent agreement towards attitude statements are displayed in Table 4. The
majority of participants agreed that research benefits society and that participation in research
means better care. Opposingly however, only 3.3% (n=51) of respondents agreed that research
conducted in the United States is ethical. Attitudes towards researchers were generally positive
in that only a few, 5.5% (n=119), agreed that “Researchers don’t care about me” and “Scientists
cannot be trusted” (2.4%, n=51).
Spearman correlations were performed using the racial groupings of White, AA,
Hispanic, Native American, Asian, and Middle Eastern. As mentioned previously in the project
design section, the correlations utilized education, trust level, and attitudes regarding
participating in research. Correlation results are displayed in Table 5. Correlations were not
performed for the Native Hawaiian grouping due to a small sample size (n<5). Trust was
significantly associated with agreement in each attitude statement from both white and AA
respondents (p<.001), however association with education level was variable. Trust level was
negatively associated with agreement towards the statement “Researchers don’t care about me”
in White (CC=-.492; p=.000), AA (CC=-.188; p=.000), Asian (CC=-.429; p=.041), and Middle
Eastern (CC=-.864; p=.003) respondents. Trust level was strongly associated with specific
attitude statements for Native American respondents but there was less evidence of associations
involving their education level. Conversely in Asian respondents, education level was positively
associated with the statements “Participation in research is morally wrong” (CC=.540; p=.008),
“Scientists cannot be trusted” (CC=.568; p=.005), “Research conducted in the US is ethical”
(CC=.453; p=.030), and “It is better to be treated by doctors who are researchers” (CC=.418;
p=.047).
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Discussion

The purpose of the scholarly project was to determine how stakeholder race, trust, and
level of education influence participation barriers in clinical research. Although the respondent’s
attitude scores towards research participation is not the exact determination of whether the
participant will or will not engage in clinical research, the attitude score may be considered a
proxy for the act of engaging in clinical research.
Overall, this cross-sectional survey of adults in the Southeastern US demonstrates
favorable attitudes towards research participation. The data suggest that attitudes are positive in
regard to perceived societal benefit and the belief that research leads to better medical care. The
attitudes towards research are consistent with both the findings of Mouton et al (1995) and
Brewer et al (2014). In addition, the research of Kraft et al (2018) displayed similar themes
during focus group interviews of AAs, Chinese, Hispanic, White, and Asians who agreed that
research would benefit society and in general, improve medical care. Although favorable
attitudes towards research participation are seen within the data, the relationship of attitudes and
an individual’s race, trust, and education is important to consider in the context of the theoretical
framework of the project and implications for future clinical practice.
Race and Ethnicity
No statistical tests were performed to analyze the correlation between race and attitudes
towards research participation within the scholarly project. As explained previously in the
methods section, the data was separated by racial groupings in order to consider race within
statistical tests that do not allow for nominal variables. The scholarly project results display
variability between racial groupings in education level, trust level, and attitudes towards
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participating in research. One cannot assume, however, statistically correlated relationships
between a respondent’s race and attitudes towards participating in research.
The difference of trust and education between White, AA, Hispanic, NA, Asian, and MEs
support the theoretical underpinnings of the scholarly project. The Social Cognitive Theory
considers an individual’s personal factors like race and ethnicity, however, the predictive weight
of the personal factor in direct correlation to participating in research is uncertain.
Trust
The findings of the scholarly project display strong evidence that an individual’s trust in
clinical research influences one’s attitude towards research. In White, AA, Hispanic, NH, and
ME respondents, trust is correlated more often to attitudes towards research than an individual’s
education level. The findings are consistent with past literature displaying the significant role
that trust has in a patient’s barriers and facilitators in participating in clinical research (George,
Duran, & Norris, 2014). In addition, the findings support the original hypothesis that trust is
predictive towards barriers in clinical research. As respondents agreed more to negative
statements regarding participation like, “Researchers don’t care about me”, “Participation in
research is risky”, and “Participation in research is morally wrong”, trust level was decreased. As
respondents agreed more with the statements “Participation will mean better care”, “Participation
in research is enjoyable”, and “Participation in research allows me to socialize”, trust level
expectedly also increased.
The relationship between trust and the respondent’s attitude towards research also aligns
with the theorized relationship of variables explained through the Social Cognitive Theory.
Through the theoretical model and the supporting data, stronger evidence exists to predict if an
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individual has greater trust towards medical research, attitudes towards research are more
favorable, and participation is more likely to occur.
Education
Overall, less evidence supported correlations between a participant’s level of education
and attitude on research participation. These findings are generally inconsistent with past
research regarding barriers to research participation. Past literature displays that low education
levels can contribute to decreased research participation due to the difficulty of understanding
the research information or the informed consent process (Asare, Flannery & Kamen, 2017;
Baquet, Commiskey, Mullins & Mishra, 2006; Crosson, Eisner, Brown, & Ter Maat, 2001). In a
qualitative survey of Hispanic beliefs about biomedical research participation, the researchers
found that participants discussed not having a formal education which acted as a barrier for
participating in research from fear of the unknown (Ceballos et al., 2014). However, the findings
of the scholarly project display less evidence of a correlation between education level and
attitudes towards research participation in Hispanic individuals.
The results of the scholarly project suggest that education level may hold a stronger
influence on attitudes towards research for Asian respondents compared to the influence of trust.
The results contradict what is commonly discussed in medical literature regarding Asian
American reverence and respect to healthcare providers (Gaw, 2020). Past literature expresses
how language barriers and health literacy are common barriers for Asian Americans when
navigating the healthcare system (Kim & Keefe, 2010; Tu et al., 2005) which may align with an
individual’s education level, particularly if they were educated in the US.
Generally, education level is not a largely predictive variable in its influence of research
participation unlike what was hypothesized. Although it shows stronger evidence of influence
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depending on race and attitude statement, it is not as consistent as the influence of trust level.
The dynamic, reciprocal relationship between personal and environmental factors of the Social
Cognitive Theory is important to consider in regard to the relationship of education level on an
individual’s participation in research. Although education can have influence on an individual’s
behavior, a variety of personal and environmental factors exist that may hold stronger influence
towards behavior. The inconsistency of an individual’s education level on attitudes towards
research participation within this scholarly project can ultimately highlight that numerous factors
have the ability to play a role in research participation.
Implications for Practice and Future Directions
The findings of the scholarly project have several implications. The variability in results
support the Social Cognitive Theory in that numerous factors influence an individual’s decision
to participate in research. Clinicians must be aware of the factors that contribute to an
individual’s attitude toward research and educate accordingly. A staggering 97% (n=2,079) of
respondents within the dataset agreed that research conducted in the US is unethical. The results
of this study are even more than Brewer et al (2014) of which half of survey respondents agreed
that research in the US is unethical. As the results show, an individual can believe that research
benefits society while also perceiving research to be unethical. The fear of unethical treatment
may outweigh the altruistic motivation of how research benefits society, therefore hindering the
participants’ engagement in research. Increased clinician education regarding the socio-cultural
barriers that hinder patients from participating can enhance clinician-patient communication.
Utilizing multiple recruitment methods for engaging participants may also be helpful.
Researchers may consider engaging with community representatives, community networks, and
churches to engage individuals (Luebbert & Perez, 2016). A newer model of research
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engagement, community-based participatory research (CBPR), displays encouraging recruitment
results (Scharff et al., 2010). CBPR operates on long term community-research relationships
(Scharff et al., 2010) and can improve knowledge gaps within communities regarding disclosure
and transparency, fear of research procedures, and societal impact in relation to research trials
(Cortes et al., 2017). In one study, Chadiha et al., (2011) utilized a CBPR framework to build a
research volunteer registry. The community-based recruitment initiatives increased the registry
from 102 to 1,273 individuals enrolled (Chadiha et al., 2011). In addition, increased ethnographic
research, particularly for highly underrepresented races and subgroups, may be helpful in
recognizing barriers to participating in research that are not as culturally explicit (George, Duran,
& Norris, 2014).
Due to the overall favorable attitudes towards participating in research displayed in the
scholarly project, it warrants the question if individuals are being exposed to research
participation opportunities through their medical providers. The data collected by Pinto et al
(2014) found that medical providers with greater education and experience were more involved
in the recruitment and facilitation of research specifically with underrepresented populations.
Patients, although possibly willing to participate in research, may have little to no knowledge of
the trials occurring if providers have a more limited lens on research opportunities. In outpatient
clinical settings, providers state that time constraints, forgetting to recruit, and the small number
of eligible individuals act as barriers in recruiting patients into research (Page, French,
McKenzie, O’Connor & Green, 2011).
The findings from the scholarly project can be used to enhance the ongoing efforts of
recruiting and engaging participants, specifically underrepresented populations, in clinical
research. It would be beneficial to consider clinician’s effectiveness with recruitment efforts
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based on practice setting. The distribution of medical providers varies depending on rural and
urban regions and specialty care settings (AHRQ, 2012). Currently, more physicians are
practicing in urban, specialty areas compared to Physician Assistant’s and Nurse Practitioners
who are more commonly in rural and primary care settings (AHRQ, 2012). It is possible that
providers who are working within academic or large medical centers in urban areas have greater
exposure to research engagement opportunities for their patients compared to more communitybased providers. In addition to provider exposure to research recruitment efforts, the scholarly
project warrants greater exploration in the role of Doctor of Nursing Practice (DNP)practitioners within the context of research. The DNP role functions to support the closure of the
research-practice gap, specifically by exploring evidence-based research questions grounded in
clinical practice (Weierbach, Glick, Fletcher, Rowlands, & Lyder, 2011). For DNPs, research
initiatives or recruitment may be easier because the practitioner is trained with a greater lens for
research.
Limitations
In light of this study’s strengths, several limitations are acknowledged. Sampling bias is
possible in that individuals holding negative attitudes toward research participation were less
likely to complete a survey and are therefore underrepresented in the sample. The data were
collected between 2014 and 2016, therefore it is becoming more outdated. In addition, due to the
nature of utilizing a secondary data source, a precise response rate is unable to be calculated. In
order to understand the relationship between variables, Spearman’s correlation was an
appropriate statistical test. However, performing a correlation between every attitude score, trust
level, and education level for each racial category allows for greater opportunities for false
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positives. Cross-sectional research designs allow for correlational analyses; however, it is
difficult to derive a causal relationship between variables.
Conclusion
Engaging and recruiting participants, particularly from minority populations, in clinical
research is a national priority. Research allows for increased knowledge in healthcare delivery
and treatment which ultimately allows for effective, equitable, and patient centered care. Without
diversity in research participants, the health disparities already occurring within minority
populations will only worsen. The results of the scholarly project, aligned with past literature,
support the importance of trust within the patient and provider relationship and that numerous
variables contribute to a patient’s attitude towards participating in research. Medical providers
involved in recruiting and engaging participants in research must have heightened awareness,
consideration, and appreciation of the complex relationships of personal and environmental
factors that make a participant and their attitudes, specifically towards research, unique.
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Figure 1. Core concepts of the Social Cognitive Theory with variables used in the scholarly
project.
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Appendix 1.
The first set of questions tells us about you and your background.

1. What is the year of your birth



Year___________

2. What is your race or ethnicity (Check all that apply)
Other, please specify



Asian (i.e. Asian Indian,
Chinese, Filipino, Japanese,
Korean, Vietnamese, Hmong,
Laotian, Thai, Pakistani,
Cambodian, etc.)
Black, African American,
African, or Afro-Caribbean
Hispanic, Latino, Spanish
origin
Middle Eastern/North African
Native American, American
Indian, Alaskan Native
Native Hawaiian, Samoan
White
Some other race, please
specific
Prefer not to answer
Male
Female
Other
Prefer not to answer
Now married
Living with a partner or
significant other
Widowed
Divorced
Separated
Never married
Prefer not to answer
8th grade or less
Some high school, but did not
graduate
High school graduate or GED
Some college or 2 year degree
Prefer not to answer
Employed Full Time (32+
hours a week)
Employed Part Time (less
than 32 hours per week
Unemployed
Volunteer
Stay-at-home parent
Retired
Receiving disability
Other, Please Specify___









3. What is your sex
If other, please specify:

4. What is your marital status?

5. What is the highest degree or level of school you completed?

6. Are you currently:
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7. How many people live in your home (including yourself)?
8. Have you visited your doctor in the past year?
9. If yes, please select the clinic
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10.

Do you have a cell phone?

11.

How often do you text?

12.

Can you access the internet using your phone?

13.

Do you have access to the internet at home?

14.

How confident are you using computers?




















______________
Yes
No
Vanderbilt University
Medical Center
Vanderbilt University
Children’s Hospital
Vanderbilt University
Stallworth Rehabilitation
Hospital
Vanderbilt University
Psychiatric Hospital
Vanderbilt University
Outpatient Practices
Meharry/Metro General
Hospital
Matthew Walker Community
Health Center
Prefer not to answer
Other, _______
Yes
No
Not at all
Not often
Somewhat often
Often
Very Often
Yes
No
Yes
No
Very confident
Confident
Fairly Confident
Not Confident
Prefer not to say

Many patients have trouble understanding the medical information they get at the hospital or
doctor’s office.
15.

How confident are you filling out medical forms by
yourself?







Extremely
Quite a bit
Somewhat
A little bit
Not at all

16.

How often do you have someone help you read hospital
materials?







All of the time
Most of the time
Some of the time
A little of the time
None of the time

BARRIERS TO PARTICIPATION
17.

How often do you have problems learning about your
medical conditions because of difficulty understanding
written information?
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All of the time
Most of the time
Some of the time
A little of the time
None of the time

The next few questions ask about your experience and feelings about working with numbers.
18.

How good are you at working with fractions?







19.

How good are you at figuring out how much a shirt will cost
if it is 25% off?







20.

How often do you find numerical information to be useful?







Not at all good/Not at all
often
Pretty good/Somewhat often
Good/Often
Very good/Very Often
Extremely good/extremely
often
Not at all good/Not at all
often
Pretty good/Somewhat often
Good/Often
Very good/Very Often
Extremely good/extremely
often
Not at all good/Not at all
often
Pretty good/Somewhat often
Good/Often
Very good/Very Often
Extremely good/extremely
often

How familiar are you with the following words or phrases?
21.

Genetic Testing

22.

Biological Indicators/Biomarkers

23.

Precision Medicine

24.

Pharmacogenetics






















Not at all familiar
Slightly familiar
Somewhat familiar
Moderately familiar
Extremely familiar
Not at all familiar
Slightly familiar
Somewhat familiar
Moderately familiar
Extremely familiar
Not at all familiar
Slightly familiar
Somewhat familiar
Moderately familiar
Extremely familiar
Not at all familiar
Slightly familiar
Somewhat familiar
Moderately familiar
Extremely familiar
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To help guide future research and healthcare, how important are the following to you?

25.

My healthcare is specific to me. No two cases are the same.







Not at all important
Slightly important
Somewhat important
Moderately important
Extremely Important

26.

My genes can be used to determine the best treatment for
me.







Not at all important
Slightly important
Somewhat important
Moderately important
Extremely Important

27.

My genes and other health information can be used to help
prevent or treat health conditions in my family.







Not at all important
Slightly important
Somewhat important
Moderately important
Extremely Important

28.

My health information is kept private and secure







Not at all important
Slightly important
Somewhat important
Moderately important
Extremely Important

29.

I have access to my own health records and can decide
which health care providers and researchers have access to
them.







Not at all important
Slightly important
Somewhat important
Moderately important
Extremely Important

30.

I can add information about my health to my health
records.







Not at all important
Slightly important
Somewhat important
Moderately important
Extremely Important

31.

Do you have any of the following? Check all that apply

32.

Household income















No health conditions
High Blood Pressure
Heart Disease
Heart Attack
Overweight or obese
Diabetes
Asthma
Sickle Cell Disease
Other
Prefer Not to Say
Less than $10,000
$10,000-$14,999
$15,000-$44,999

BARRIERS TO PARTICIPATION
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Health Insurance Category
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$25,000-$34,999
$35,000-$49,999
$50,000-$74,999
$75,000-$994,999
$100,000-$149,999
$150,000 or more
Insured
Uninsured (No Insurance)
Medicaid (TennCare)
Medicare
Self Pay
Other

The next set of questions tells us about your experience with research.

34.
35.
36.

Prior to today, have you ever been asked to participate in
research?
Prior to today, have you ever participated in health-related
research?
If yes, how would you describe the research?














37.

In general, what would be the preferred contact methods to
learn about potential research studies? Select all that apply.











Yes
No
Yes
No
A study comparing treatments
or prevention methods
(clinical trial)
Testing to determine if you
are high risk for a certain
disease
Testing to determine if a
condition has been passed
down in your family
(inherited)
In person-focus group,
facilitated discussion or
survey of attitudes, beliefs, or
behaviors
An online questionnaire or
survey of attitudes, beliefs or
behaviors
Blood, tissue, or other body
fluid was collected for use in
any current or future research
Other
Email
Cell phone text
Social media (Facebook or
twitter)
Letter or postcard in the mail
A computer created phone
message
Personal phone call from
research staff or my doctor
Talking face to face
Other

BARRIERS TO PARTICIPATION
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I am not interested in being
contacted about future
research studies

If a research study was studying a condition or health problem that you care about, would you
participate if it required….

38.

Completing a survey two or more times

39.

Giving a blood sample

40.

Taking part in a study that involves by phone or over the
internet (for example, to get advice about your health)

41.

Taking part in a study that involves meeting at a local
community center or school

42.

Taking part in a study that involves you and other people in
your family

43.

Taking part in a study in which you would stay in the
hospital for one or more days

44.

What sources do you most often use to find information
about health or medical topics? Check all that apply.






























Not Interested
Somewhat Interested
Very Interested
Not Interested
Somewhat Interested
Very Interested
Not Interested
Somewhat Interested
Very Interested
Not Interested
Somewhat Interested
Very Interested
Not Interested
Somewhat Interested
Very Interested
Not Interested
Somewhat Interested
Very Interested
Family
Friend/Co-worker
Doctor or other health care
professional
Internet
Radio, newspaper or
magazine
Telephone, information
number of disease-focused
group such as the American
Cancer Society or the
American Heart Association
Complementary, alternative
or unconventional practitioner
I have never looked for
information about health or
medical topics
Other, please
describe_______

In general, how much do you trust information about health or medical topics from each of the
following?

45.

Doctor



Not at all

BARRIERS TO PARTICIPATION

46.

Other healthcare provider (nurse, pharmacist, or other
professional who provides care)

47.

Family or friend

48.

Online community for patients or caregivers dealing with
the same health condition

49.

Disease-focused groups such as the American Cancer
Society or the American Heart Association

50.

Your health insurance company

51.

Internet

52.

Television, radio, newspaper, or magazines

53.

Government health agencies
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A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot
Not at all
A little
Some
A lot

Please indicate to what degree you agree or disagree with the following statements regarding
participation in research

54.

Please indicate to what degree you agree or disagree with
the following statements regarding participation in research
Participation in clinical research benefits society

55.

Participation will mean better care

56.

Participation in research is risky













Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree

BARRIERS TO PARTICIPATION

57.

Researchers do not care about me

58.

Participation in research is enjoyable

59.

Participation in research allows me to socialize

60.

Participation in research is against my religion

61.

Participation in research is morally wrong

62.

Transportation is a problem for people who participate

63.

Scientists cannot be trusted

64.

It is better to be treated by doctors who are researchers

65.

Which of the following are barriers for you when
considering participating in research? Check all that apply
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Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Strongly disagree
Disagree
Neither agree nor disagree
Agree
Strongly Agree
Technical language on study
materials (i.e. flyers,
brochures, text messages,
consent form, etc.)
Cultural appropriateness of
study materials (i.e. flyers,
brochures, text messages,
consent form, etc.)

BARRIERS TO PARTICIPATION
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Burden to yourself or your
family (i.e. time, cost, social
acceptance)
The feeling of being
undervalued or poorly treated
by health care system
Limited access to research
studies
Personal attitude towards
research in general
Limited resources to
participate in research (i.e.
transportation, phone,
internet, etc.)
Lack of sensitivity from the
researcher
Lack of trust/mistrust/distrust
Lack of
motivation/willingness
Fear
Religious/spiritual beliefs
Lack of awareness of studies
(i.e. poor advertisement in
your environment)
The feeling that your health
condition is stigmatized by
society/health system/health
providers (i.e. obesity, mental
health, etc.)
Restricted eligibility criteria
(i.e. being turned away
because you did not fit the
screening criteria)
Other






Ethical
Not Ethical
Don’t know
Other
















66.

In my opinion, research in the United States is

The following 12 questions ask about your views on research. There are no right or wrong answers.
For each statement below, please indicate how strong you agree or disagree with it.

67.

Doctors who do medical research care only about what is
best for the patient

68.

Medical researches treat people like “guinea pigs”











Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree

BARRIERS TO PARTICIPATION

69.

It’s safe to be in a medical research study

70.

Some doctors do medical research for selfish reasons

71.

Doctors tell their patients everything they need to know
about being in a research study

72.

A doctor would never ask me to be in a medical research
study if the doctor thought there was any chance it might
harm me.

73.

There are some things about medical research that I do not
trust at all.

74.

A doctor would never recommend something that is not the
best treatment just so he or she can study how it works

75.

Medical researchers have no selfish reasons for doing
research studies

76.

Medical researchers do not tell people everything they
really need to know about being in a research study

77.

The only reason doctors do medical research is to help
people

78.

I completely trust doctors who do medical research
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Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly disagree
Disagree
Neutral
Agree
Strongly Agree

BARRIERS TO PARTICIPATION
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Table 1
Sociodemographic characteristics of survey respondents (N=2,149)
Characteristic
Gender
Male
Female
Other
Race
White
African American
Hispanic
Native American
Asian
Prefer not to answer
Middle Eastern
Native Hawaiian
Education
8th grade or less
Some high school did not graduate
High school graduate or GED
Some college or 2-year degree
College degree
More than a college degree
Prefer not to answer
Employment
Full Time
Part Tim (<32hr)
Unemployed
Volunteer
Stay at home parents
Retired
Receiving disability
Other
Insurance
Insured
Uninsured
Medicaid
Self-Pay
Other
Household Income
<$10,000
$10,000-$14,999
15,000-24,999
25,000-34,999
35,000-49,999

n

%

640
1496
6

29.0
69.0
0.3

1701
341
57
40
23
14
9
4

77.7
15.6
2.6
1.9
<1
<1
<1
<1

17
59
214
543
622
671
16

0.8
2.7
9.9
25.2
28.8
31.3
0.7

1078
193
108
22
87
351
158
143

50.4
9.0
5.0
1.0
4.1
16.4
7.4
6.7

1610
68
73
318
37

76.0
3.2
3.4
15.0
1.7

142
72
136
197
233

7.5
3.8
7.2
10.4
12.3

BARRIERS TO PARTICIPATION
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50,000-74,999
75,000-99,999
100,000-149,999
150,000 or more

356
288
260
218

18.7
15.1
13.7
11.5

Table 2
Trust statistics by racial grouping
Race

All
White
African American
Hispanic
Native American
Asian
Prefer not to answer
Middle Eastern
Native Hawaiian

Trust
M
39.85
40.33
37.79
37.92
37.85
40.26
40.36
36.11
40.22

Note. n = frequency; M= Mean; SD = standard deviation

SD
6.7
6.6
6.7
7.3
6.8
4.9
6.6
5.8
9.4

Running head: BARRIERS TO PARTICIPATION
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Table 3
Education level by racial grouping
Race

n %
17 0.8

n %
4 0.2

African
American
(n=341)
n %
12 3.5

59 2.8

19 1.1

35 10.3

3 5.3

High school 214 9.9
graduate or
GED
Some college or 543 25.2
2-year degree

149 8.8

61 17.9

440 25.9

College degree 622 29.0
More than a 671 31.1
college degree

Education Level
th

8 grade or less
Some high
school did not
graduate

Prefer not to
answer

Total
(N=2149)

16 0.7

White
(n=1701)

Hispanic
(n=57)

n %
- -

Middle
Eastern
(n=9)
n %
- -

1 42.5

- -

- -

-

-

- -

5 8.8

6 15.0

- -

- -

-

-

- -

80 23.5

11 19.3

16 40.0

6 26.1

1 11.1

1 25.0

5 35.7

515 30.3

76 22.3

23 40.4

7 17.5

7 30.4

2 22.2

3 75.0

3 21.4

567 33.3

72 21.1

13 22.8

10 25.0

9 39.1

6 66.7

-

-

5 35.7

7 0.4

5 1.5

2 3.5

1 4.3

- -

-

-

1 7.1

n %
- -

Native
American
(n=40)
n %
- -

- -

Asian
(n=23)

Native
Hawaiian
(n=4)
n %
-

Prefer not
to answer
(n=14)
n %
- -

BARRIERS TO PARTICIPATION
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Table 4
Percentage of survey respondents reporting agreement with each attitude statement

Research participation attitude statement
Participation in research benefits society
Participation in research will mean better care
Participation in research is risky
Researchers don’t care about me
Participation in research is enjoyable
Participation in research allows me to socialize
Participation in research is against my religion
Participation in research is morally wrong
Transportation is a problem for research participants
Scientists cannot be trusted
Research conducted in the US is ethical
It is better to be treated by doctors who are researchers
Note: Agreement combines the responses: “agree” and “strongly agree.”

Agreement (N=2149)
n
%
1954
90.9
1649
532
119
731
379
35
33
357
51
70
687

76.7
24.8
5.5
34.0
17.6
1.6
1.5
16.6
2.4
3.3
31.9

BARRIERS TO PARTICIPATION
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Table 5
Spearman correlations between attitude statements, trust score, and education level by each racial category
Statement
Participation in
research
benefits society
Participation in
research will
mean better
care
Participation in
research is
risky
Researchers
don’t care
about me
Participation in
research is
enjoyable
Participation in
research allows
me to socialize
Participation in
research is
against my
religion
Participation in
research is
morally wrong

White
(n=1701)

African American
(n=341)

Hispanic
(n=57)

Native American
(n=40)

Asian
(n=23)

Middle Eastern
(n=9)

Trust

Education

Trust

Education

Trust

Education

Trust

Education

Trust

Education

Trust

Education

CC .281**
.000

CC .182**
.000

CC .225**
.000

CC .293**
.000

CC .96
.140

CC .241
.071

CC .137
.392

CC .289
.071

CC .193
.377

CC .067
.760

CC -.087
.823

CC .207
.593

CC .333**
.000

CC.024
.323

CC .331**
.000

CC: .037
.499

CC .388**
.003

CC .146
.278

CC .443**
.004

CC .114
.483

CC .181
.409

CC .019
.930

CC -.276
.472

CC .245
.524

CC -.238**
.000

CC -.082**
.001

CC -.154**
.004

CC .139*
.010

CC -.021
.877

CC -.218
.104

CC -.311*
.048

CC .115
.481

CC -.245
.260

CC .115
.601

CC -.315
.410

CC .000
1.0

CC -.492**
.000

CC -.035
.154

CC -.188*
.000

CC -.068
.208

CC -.305*
.020

CC .140
.300

CC -.567**
.000

CC .067
.681

CC -.429*
.041

CC .346
.106

CC-.864**
.003

CC .245
.525

CC .312**
.000

CC .054*
.025

CC .249**
.000

CC -.007
.903

CC .445**
.000

CC -.085
.530

CC .429**
.005

CC -.203
.208

CC .057
.796

CC .123
.575

CC .678*
.045

CC .371
.325

CC .165**
.000

CC -.108**
.000

CC .222**
.000

CC -.083
.126

CC .283*
.031

CC -.085
.530

CC .416**
.007

CC -.226
.161

CC -.074
.738

CC .028
.897

CC .180
.644

CC -.491
.179

CC -.201**
.000

CC -.144**
.000

CC-.117*
.029

CC -.122*
.024

CC -.056
.676

CC -.176
.191

CC.149
.352

CC .032
.843

CC -.248
.255

CC .235
.280

CC .000
1.0

CC -.546
.129

CC -.230**
.000

CC -.152**
.000

CC-.119*
.026

CC -.128*
.018

CC -.144
.280

CC -.342**
.009

CC .314*
.046

CC -.064
.696

CC -.279
.198

CC .540**
.008

CC -.052
.894

CC -.124
.751

BARRIERS TO PARTICIPATION
Transportation
is a problem for
research
participants
Scientists
cannot be
trusted
Research
conducted in
the US is
ethical
It is better to be
treated by
doctors who are
researchers
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CC -.222**
.000

CC .018
.464

CC -.146**
.006

CC -.036
.506

CC .041
.757

CC -.152
.260

CC -.285
.071

CC -.146
.369

CC .067
.761

CC -.381
.073

CC .347
.361

CC -.220
.569

CC -.395**
.000

CC -.163**
.000

CC -.236**
.000

CC -.105
.052

CC -.233
.092

CC -.173
.198

CC -.303
.054

CC .102
.532

CC -.148
.501

CC .568**
.005

CC -.663
.052

CC -.161
.680

CC -.328**
.000

CC -.116**
.000

CC -.171**
-.001

CC -.236**
.000

CC -.497**
.000

CC .144
.284

CC .001
.995

CC .256
.110

CC -.124
.572

CC .453*
.030

CC -.522
.150

CC .371
.325

CC .101**
.000

CC .041
.089

CC .106*
.047

CC -.010
.850

CC .115
.390

CC .084
.535

CC .049
.759

CC -.240
.137

CC -.246
.258

CC .418*
.047

CC .518
.153

CC -.068
.862

Note: CC is Spearman Correlation Coefficient.
Second value is p value. *p<.05, **P<.01
Attitude statements are scored toward agreement, level of trust is scored such that higher scores indicate greater respondent trust in medical research

